- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 0.0 | - |
Min SIP Amount | ₹1000 | - |
Expense Ratio | 0.93 | - |
NAV | ₹16.56 | - |
Fund Started | 25 Nov 2022 | - |
Fund Size | ₹78.96 Cr | - |
Exit Load | - | - |
Risk
Very High
-
Rating
0.0
-
Min SIP Amount
₹1000
-
Expense Ratio
0.93
-
NAV
₹16.56
-
Fund Started
25 Nov 2022
-
Fund Size
₹78.96 Cr
-
Exit Load
-
-
Returns
1 Year | 36.21% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
36.21%
-
3 Year
-
-
5 Year
-
-
Holding Analysis
Equity | 100.36% | - |
Cash | -0.36% | - |
Equity
100.36%
-
Cash
-0.36%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 25.18% |
Cipla Ltd. | 10.76% |
Dr. Reddy's Laboratories Ltd. | 9.80% |
Divi's Laboratories Ltd. | 9.43% |
Lupin Ltd. | 6.65% |
Aurobindo Pharma Ltd. | 4.92% |
Alkem Laboratories Ltd. | 3.81% |
Torrent Pharmaceuticals Ltd. | 3.73% |
Glenmark Pharmaceuticals Ltd. | 3.22% |
Mankind Pharma Ltd. | 3.17% |
-
Fund Manager
Name | Kayzad Eghlim | - |
Start Date | 03 Dec 2021 | - |
Name
Kayzad Eghlim
-
Start Date
03 Dec 2021
-
About Fund
Description | The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index | - |
Launch Date | 25 Nov 2022 | - |
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
-
Launch Date
25 Nov 2022
-
